Changes in Oxygenation and Serological Markers in Acute Exacerbation of Interstitial Lung Disease Treated with Polymyxin B Hemoperfusion.
Song I LeeChaeuk ChungDong Il ParkDa Hyun KangJeong Eun LeePublished in: Journal of clinical medicine (2022)
In patients with AE-ILD, PMX-DHP treatment was associated with an improved P/F ratio and lower WBC and CRP levels.